The
contrasts of Québec...
|
During
this first full-scale meeting of the society (with an attendance of approx.
200), the following topics were covered during the plenary sessions:
-
Use of in vitro and animal models
to quantify pharmacokinetics and pharmacodynamic parameters predisctive
of effeicacy in humans (A.A. Craig, USA)
-
The relevance of serum versus
tissue concentrations for antibiotic pharmacodynamics (O. Cars, Sweden)
-
Pharmacodynamics of quinolones
(H. Lode, Germany)
-
Pharmacodynamics of aminoglycosides
(Ch. Nightingale, USA)
-
Pharmacodynamics of beta-lactame
antibiotics (J. Turnidge, Australia)
-
Pharmacodynamics of macrolides,
azalides and streptogramins (extracellular organisms) (C. Carbon, France)
-
Pharmacodynamics of antimicrobials
against intra-cellular pathogens (P.M. Tulkens, Belgium)
-
Pharmacodynamics of glycopeptides
and lipopetides: lessons to be learned from daptomycin (M. Zeckel, USA)
-
Pharmacodynamics considerations
in susceptibility guidelines (R. Jones, USA)
-
Pharmacodynamics of antivirals
(G. Drusano, USA)
-
New approaches in the study
of antiviral pharmacodynamics (M. Dudley, USA)
-
Modelling the effects of single
and combination antibiotic regimens in vitro, in normal volunteers, and
in patients (J.J. Schentag, USA)
-
Optimal dosing regimens and
pharmacoeconomics
In addition, 30 posters were
presented and discussed.
|
Back
to ISAP home page